- Home
- AQST vs ACV Comparison
AQST vs ACV Comparison
Compare AQST & ACV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- ACV
- Stock Information
- Founded
- AQST 2004
- ACV 2015
- Country
- AQST United States
- ACV United States
- Employees
- AQST N/A
- ACV N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- ACV Finance/Investors Services
- Sector
- AQST Health Care
- ACV Finance
- Exchange
- AQST Nasdaq
- ACV Nasdaq
- Market Cap
- AQST 274.4M
- ACV 233.8M
- IPO Year
- AQST 2018
- ACV N/A
- Fundamental
- Price
- AQST $3.02
- ACV $19.83
- Analyst Decision
- AQST Strong Buy
- ACV
- Analyst Count
- AQST 7
- ACV 0
- Target Price
- AQST $10.57
- ACV N/A
- AVG Volume (30 Days)
- AQST 1.3M
- ACV 38.8K
- Earning Date
- AQST 03-05-2025
- ACV 01-01-0001
- Dividend Yield
- AQST N/A
- ACV 9.20%
- EPS Growth
- AQST N/A
- ACV N/A
- EPS
- AQST N/A
- ACV N/A
- Revenue
- AQST $57,561,000.00
- ACV N/A
- Revenue This Year
- AQST N/A
- ACV N/A
- Revenue Next Year
- AQST $35.72
- ACV N/A
- P/E Ratio
- AQST N/A
- ACV N/A
- Revenue Growth
- AQST 13.79
- ACV N/A
- 52 Week Low
- AQST $2.24
- ACV $16.82
- 52 Week High
- AQST $5.80
- ACV $23.74
- Technical
- Relative Strength Index (RSI)
- AQST 50.92
- ACV 31.15
- Support Level
- AQST $3.05
- ACV $20.20
- Resistance Level
- AQST $3.24
- ACV $20.99
- Average True Range (ATR)
- AQST 0.20
- ACV 0.44
- MACD
- AQST 0.04
- ACV 0.05
- Stochastic Oscillator
- AQST 57.47
- ACV 4.92
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest
Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It seeks to achieve its investment objective by investing in a combination of convertible securities, debt and other income-producing instruments and common stocks and other equity securities.